Express News | Aonong Biotech: The company's shares will be subject to a delisting risk warning
Express News | Aonong Biotech: First quarter revenue of 2,408 billion yuan, a year-on-year decrease of 50.02%
Tiankang Biotech (002100.SZ): Net profit of 54.638 million yuan for the first quarter reversed the year-on-year loss
Gelonghui, April 29丨Tiankang Biotech (002100.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 3.777 billion yuan, down 2.93% year on year; net profit attributable to shareholders of listed companies was 54.638 million yuan, which turned a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 56.773 million yuan; basic earnings per share were 0.04 yuan.
Jingji Zhinong (000048.SZ): Net profit of 54.1251 million yuan in the first quarter decreased by 95.56% year-on-year
Gelonghui, April 29丨Jingji Zhinong (000048.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 1,258 billion yuan, down 81.12% year on year; net profit attributable to shareholders of listed companies was 54,1251 million yuan, down 95.56% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 589.06 million yuan, down 95.28% year on year; basic earnings per share were 0.1034 yuan.
Dongrui Co., Ltd. (001201.SZ): Net loss of 83.08,600 yuan in the first quarter, a year-on-year decrease in losses
Gelonghui, April 29丨Dongrui Co., Ltd. (001201.SZ) released its first quarter report. Operating income was 280 million yuan, down 13.95% year on year, net loss of 83.40,600 yuan, year-on-year loss, minus non-net loss of 83.41 million yuan. The year-on-year loss was reduced. The basic income per share was -0.32 yuan.
Xinwufeng (600975.SH): Net loss of 254 million yuan in the first quarter
Gelonghui, April 29丨Xinwufeng (600975.SH) released its report for the first quarter of 2024, achieving operating income of 1.43 billion yuan, an increase of 16.98%; net profit attributable to shareholders of listed companies - 254 million yuan, net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 256 million yuan, and basic earnings per share - 0.2 yuan.